Materials • Major Chemicals
$1.77 ▼ -0.08
(-4.32%)
MKT CAP: $77.3M • VOL: 221.3K
52W L $2 52W H $7
ROARABLE / RQD
E • 31/100
PIOTROSKI
3 / 9
ARQ // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$53.0M | -$2.0M | -$13.3M |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$52.6M | -$5.1M | -$12.2M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.7M | $10.5M | -$16.7M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$2.7M | $10.5M | -$16.7M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | -24.6% | -0.7% | — |
| Cash & Short-Term Equivalents | $6.6M | $13.5M | — |
| Total Debt (Short + Long Term) | $8.5M | $9.4M | — |
| Total Stockholders' Equity | $168.4M | $218.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ARQ.